16 Jul 2025
// FDA
24 Jun 2025
// PR NEWSWIRE
29 Jan 2025
// PR NEWSWIRE
Latest Content by PharmaCompass
Digital content
16 Jul 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-16-2025-29456.pdf
24 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/breckenridge-pharmaceutical-announces-final-fda-approval-for-dehydrated-alcohol-injection-usp-generic-for-ablysinol-302489848.html
29 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/breckenridge-announces-final-fda-approval-for-everolimus-tablets-for-oral-suspension-ab-rated-to-afinitor-disperz-302363514.html
01 Jan 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-1-2025-88420.pdf
18 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/breckenridge-announces-final-fda-approval-for-methadone-hydrochloride-multi-dose-injection-302334969.html
26 Jun 2024
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-26-2024-3489.pdf